Equity Capital And Reserves Zmiana Data
AbbVie USD 12.09B 772M 2023-09
Abbott USD 37.17B 164M 2023-06
Amgen USD 6.23B 1.42B 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Baxter International USD 8.4B 301M 2023-12
Bayer EUR 33.38B 3.57B 2023-09
Becton, Dickinson and Co. USD 25.33B 464M 2023-12
Biogen USD 14.8B 315.6M 2023-12
Boston Scientific USD 18.89B 660M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
CONMED USD 796.2M 16.01M 2023-09
Cooper Companies USD 7.7B 144.5M 2023-12
Dexcom USD 2.07B 199.3M 2023-12
Edwards Lifesciences USD 6.65B 7.5M 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Globus Medical USD 4B 189.33M 2023-12
Hologic USD 4.65B 363.1M 2023-12
Insulet USD 732.7M 125.2M 2023-12
Integra LifeSciences USD 1.59B 8.66M 2023-12
Intuitive Surgical USD 13.4B 858.3M 2023-12
J&J USD 71.23B 3.92B 2023-09
Merck USD 41.25B 2.55B 2023-09
Merit Medical Systems USD 1.2B 27.88M 2023-12
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Stryker USD 18.59B 688M 2023-12
Tandem Diabetes Care USD 313.63M 368K 2023-12
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09
Zimmer Biomet Holdings USD 12.49B 22.7M 2023-12
Zoetis USD 5B 81M 2023-12



J&J Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.